Venöse Multiple Sklerose Hypothese | CCSVI

Die CTV W5 ist online im Internet verfügbar:

Liberation War – Why MS patients aren't waiting for proof

• W5: The Liberation War, part one (12:28)
  A experimental treatment for multiple sclerosis is pitting desperate patients against the medical community, which is demanding more testing, further studies and strict proof of the results.
• W5: The Liberation War, part two (9:31)
  Online and from around the world, patients with MS are pushing their medical systems to look at the possible link between CCSVI and the disease. The provocative theory was actually suggested and dismissed decades ago.
• W5 Extended: Opposition (0:52)
  Dr. Franz Schelling describes the opposition he faced 30 years ago.
• W5 Extended: Liberation Treatment (0:45)
  Dr. Paolo Zamboni clears up misinformation about the Liberation Treatment.
• W5 Extended: Liberation Treatment, part two (0:54)
  Dr. Paolo Zamboni proposes providing the Liberation Treatment on compassionate grounds.
• W5 Extended: Testing and treatment (1:24)
• Dr. Mark Freedman, outlines his position on CCSVI testing and treatment.
  Financial Interests of Dr. Mark Freedman:
  Dr Freedman has received research support from the Canadian MS Society, EMD Merck-Serono, Genzyme, and Bayer Schering Pharma; consultancy and speaking honoraria from Teva Neuroscience, Bayer Healthcare, and EMD Merck-Serono.
  Source: Annals of Neurology, 2010 [khan10a]
• W5 Extended: Placebo (1:25)
  Dr. Mark Freedman, explains why improvements may be due to placebo.
• W5 Extended: CCSVI research (1:14)
  Yves Savoie, outlines the M.S. Society of Canada's position on CCSVI research.